The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure.
immunomodulation
in vitro fertilization
intralipid
intravenous lipid emulsion
recurrent pregnancy loss
uterine natural killer cells
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Feb 2024
Feb 2024
Historique:
accepted:
31
01
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
epublish
Résumé
Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.
Identifiants
pubmed: 38435143
doi: 10.7759/cureus.53368
pmc: PMC10907924
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e53368Informations de copyright
Copyright © 2024, Anya et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.